TokenPost topic
1 TokenPost story is tagged Stargardt disease. The newest appear first.
The FDA set May 12, 2027, as the new action date for tinlarebant’s application for Stargardt disease type 1.
Nov 20, 2026, 12:14 PM EST · Regulation